VIA
HRMY icon

Virtus Investment Advisers’s Harmony Biosciences HRMY Stock Holding History

Virtus Investment Advisers’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
33,746
+12,906
+62% +$407K 0.29% 174
2026
Q1 		$584K Buy
20,840
+3,971
+24% +$130K 0.16% 199
2025
Q4 		$631K Buy
16,869
+3,536
+27% +$116K 0.17% 213
2025
Q3 		$367K Hold
13,333
– – 0.11% 234
2025
Q2 		$421K Buy
13,333
+2,065
+18% +$66.4K 0.14% 221
2025
Q1 		$374K Buy
11,268
+7,668
+213% +$275K 0.1% 220
2024
Q4 		$124K Buy
+3,600
New +$124K 0.1% 239

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus Investment Advisers's HRMY Position: Q2 2026 in Review

Virtus Investment Advisers increased its Harmony Biosciences (HRMY) stake by 62% in Q2 2026, buying an estimated $407K and bringing the position to 33,746 shares worth $1.23M. The position accounts for 0.29% of the portfolio, ranked #174.

Virtus Investment Advisers first reported a position in HRMY in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Virtus Investment Advisers held 33,746 shares of Harmony Biosciences worth $1.23M as of Q2 2026.
  • Virtus Investment Advisers bought 12,906 Harmony Biosciences shares in Q2 2026, an estimated $407K.
  • Harmony Biosciences made up 0.29% of Virtus Investment Advisers's portfolio in Q2 2026, its #174 holding.
  • Virtus Investment Advisers first reported a position in Harmony Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.